# CAN SLIM Progress Board

Last updated: 2026-09-14

Frozen quantitative v1 remains research-complete but not production-ready. FWD1 and EXH2 continue unchanged. The theory-fidelity path now has frozen #32/#33/#34/#35 contracts, a frozen #36 execution baseline, frozen #37 sell/risk semantics, frozen #38 daily deterioration evidence, and frozen #39 weekly/10-week evidence.

## Repository boundary for #33

**Canonical #33 implementation and P8 morphology validation live in `azharmz/ussy-oneil-patterns`.**

Frozen production contract: `oneil-pattern-output-v2` with only `FLAT_BASE`, `DOUBLE_BOTTOM`, `CUP_WITHOUT_HANDLE`, and `CUP_WITH_HANDLE`. P6 advanced patterns remain excluded and frozen.

## Theory Fidelity / v2 path

| # | Workstream | Status |
|---:|---|---|
| 25 | Theory Fidelity Audit | **COMPLETE** |
| 26 | Proper-base definitions | **COMPLETE** |
| 27 | Pivot / buy-point definition | **COMPLETE** |
| 28 | Breakout + volume confirmation | **COMPLETE** |
| 29 | RS / leadership fidelity | **COMPLETE** |
| 30 | C/A/S/I/M role fidelity | **COMPLETE** |
| 31 | Sell / risk-management fidelity | **COMPLETE** |
| 32 | Theory-faithful candidate specification | **COMPLETE / FROZEN v1** |
| 33 | O'Neil Pattern Recognition Engine | **CORE COMPLETE / FROZEN — P8 CONDITIONAL PASS** |
| 34 | Theory-faithful candidate generator | **COMPLETE / FROZEN v1** |
| 35 | New-candidate validation | **COMPLETE / FROZEN — CONDITIONAL PASS** |
| 36 | Execution / entry research | **BASELINE FROZEN / DIAGNOSTIC COMPLETE / PRIMARY PERFORMANCE VALIDATION BLOCKED_ON_ELIGIBLE_POPULATION** |
| 37 | Sell / risk execution semantics | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 38 | Technical deterioration evidence | **EVIDENCE LAYER COMPLETE / FROZEN v1** |
| 39 | Weekly aggregation / 10-week evidence | **WEEKLY AGGREGATION + 10W EVIDENCE COMPLETE / FROZEN v1** |

## #34–#35 frozen candidate/validation state

Frozen staged contract:

```text
BASE_RECOGNIZED
→ PIVOT_DEFINED
→ PIVOT_CROSSED
→ BREAKOUT_CONFIRMED
→ CANSLIM_ELIGIBLE
```

#34 final verification run `34758050282` → **SUCCESS**, 9 tests passed.

#35 canonical historical run `34763920536`: 265,642 observations, zero V35-A/B/C findings, frozen 60-case corpus. Independent source-evidence audit run `34765922653` → **SUCCESS**, C/A/L/M 60/60 MATCH, PIT violations = 0. Terminal verdict remains `CONDITIONAL PASS / VALIDATION COMPLETE WITH UPSTREAM #33 MORPHOLOGY DEBT PRESERVED`.

## #36 — Execution / Entry

Canonical baseline `36-execution-entry-v1` remains frozen:

```text
CANSLIM_ELIGIBLE at T
→ known after close T
→ causal execution convention T+1 open
→ fill iff pivot <= open <= pivot * 1.05
```

`T`, close T, T+1 and T+3 are dataset/backtest chronology labels, not O'Neil terminology.

Semantic validation run `34785545504` → **SUCCESS**, 11 passed. R0/R1/R2/R3 integrity run `34785658367` → **SUCCESS**. Primary performance validation remains `BLOCKED_ON_ELIGIBLE_POPULATION` because canonical #35 has 0 `CANSLIM_ELIGIBLE` observations. BREAKOUT_CONFIRMED diagnostic remains diagnostic-only and authorizes no variant promotion.

## #37 — Sell / Risk Execution Semantics

Contract: `37-sell-risk-v1`.

Frozen semantics include practical ~7% capital protection from actual fill, legacy 8% severity evidence, observed-open gap-through handling, +20%-25% profit-management state from pivot without mandatory full exit, exceptional-winner/eight-week context, and explicit boundaries around round-trip/climax/market exposure.

Canonical semantic-validation run `34787905360` → **SUCCESS, 10 passed**.

Terminal state: `IMPLEMENTATION COMPLETE / FROZEN v1`.

## #38 — Daily Technical Deterioration Evidence

Contract: `38-technical-deterioration-evidence-v1`.

Frozen evidence includes completed-session MA10/MA21/MA50, strict-below-MA breaks, prior-50 volume ratio, project-consistent `>=1.40x` heavy-volume evidence proxy, largest down-volume-since-breakout evidence, below-pivot evidence, and loss-from-fill evidence. #38 cannot promote a new mandatory sell action.

Canonical semantic-validation run `34788119495` → **SUCCESS, 12 passed in 0.04s**.

Terminal state: `EVIDENCE LAYER COMPLETE / FROZEN v1`.

## #39 — Weekly Aggregation / 10-Week Evidence

Specification: `docs/methodology/39-weekly-aggregation-10w-evidence-spec-v1.md`.

Contract: `39-weekly-10w-evidence-v1`.

Frozen semantics:

- ISO year/week partition;
- current in-progress ISO week excluded;
- holiday-shortened weeks remain valid completed weeks;
- weekly OHLC = first open / max high / min low / last close;
- weekly volume summed only when all component daily volumes exist;
- `ma10w` = mean of latest 10 **completed weekly closes**;
- fewer than 10 completed weeks = `NOT_EVALUABLE`;
- break only when completed weekly close is strictly below `ma10w`;
- MA50 daily is explicitly **not** treated as identical to the 10-week line;
- weekly volume ratio excludes latest completed week from prior-10 denominator;
- `>=1.40x` heavy-volume evidence remains a quantitative proxy, not a universal sell threshold;
- first-break chronology is preserved only when prior 10-week state is evaluable;
- weekly evidence becomes known only after the stream advances into a later week;
- no Friday-close hindsight execution is fabricated;
- no mandatory sell action is promoted by #39.

Implementation:

- `src/canslim_research/weekly_10w_v1.py`
- `tests/test_weekly_10w_v1.py`
- `.github/workflows/39-weekly-10w-v1.yml`

Canonical semantic-validation run:

- run `34788414986`
- job `103808042129`
- commit `2fa62e52c022e54bb2a85895cddb859eb0dd9ac6`
- **SUCCESS**
- **10 passed in 0.04s**

Freeze decision: `docs/decisions/2026-09-14-39-weekly-10w-evidence-freeze.md`.

Terminal state: `WEEKLY AGGREGATION + 10W EVIDENCE COMPLETE / FROZEN v1`.

## Forward / production boundaries

FWD1 remains LIVE / ACCUMULATING with its existing gate; EXH2 remains separate and prospective. Production integration remains blocked by the FWD1 gate. Theory-fidelity findings must not be retrofitted into FWD1/X3/EXH2.

## Active work from here

1. Keep #33/#34/#35/#36/#37/#38/#39 frozen.
2. Do not promote R1/R2/R3 or MA/heavy-volume evidence based on historical performance alone.
3. Wait for a genuine frozen `CANSLIM_ELIGIBLE` source population before primary #36/#37 performance validation.
4. Any mandatory 50d/10w sell action requires a separate explicit action specification; #38/#39 are evidence-only.
5. Round-trip action semantics, climax/exhaustion, and market-exposure action remain separate future workstreams requiring authoritative specifications.
6. Preserve #33 morphology debt, keep P6 out of production, and keep FWD1/EXH2 unchanged.